AIM ImmunoTech Inc. · AMEX:AIM
Equels Thomas K bought 12,751 AIM ImmunoTech Inc. shares (Form 4)
Traded Nov 6, 2026 · Filed Nov 9, 2026
On Nov 6, 2026, Equels Thomas K (Director, CEO & President) bought 12,751 AIM ImmunoTech Inc. shares at US$0.16 for US$2,015, leaving 222,797 shares. Filed Nov 9, 2026 (Form 4).
- Bought
- 12,751 shares
- Price
- US$0.16
- Value
- US$2,015
- Holding after
- 222,797 shares
- Trading plan
- No
- Role
- Director, CEO & President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | Common Stock | Buy | 12,751 | US$0.16 | 222,797 | Direct |
Source
Download original · View original at SEC
Related
- AIM ImmunoTech Inc.
- Equels Thomas K
- AIM ImmunoTech Inc. shareholders
- Form 4 · Equels Thomas K · Nov 20, 2026
- Form 4 · Equels Thomas K · Nov 18, 2026
- Form 4 · Equels Thomas K · Nov 17, 2026
- Form 4 · Equels Thomas K · Nov 13, 2026
- Form 4 · Equels Thomas K · Nov 12, 2026
- Form 4 · Kellner Ted D · Nov 20, 2026
- Form 4 · Equels Thomas K · Nov 10, 2026
- Form 4 · Equels Thomas K · Nov 6, 2026
- Form 4 · Equels Thomas K · Oct 26, 2026
- Form 4 · Equels Thomas K · Oct 23, 2026